 Dyslipidemia and coronary heart disease CHD are increasingly recognized in persons with human immunodeficiency virus HIV infection. Many antiretrovirals, including efavirenz EFV, are associated with increases in serum lipids. The investigators investigated whether stopping EFV and replace EFV by nevirapine can reduce significantly Low-Density Lipoprotein cholesterol, while keeping virologic control of HIV. 